Lab
Quest Diagnostics LLC
Quest Diagnostics LLC was paid $706K by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.
33Billing provider infoQUEST DIAGNOSTICS LLC
WALLINGFORD, CT 06492
WALLINGFORD, CT 06492
33aNPI1174569909assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$706K
24GClaims747,989
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Connecticut
Rank by total paid#12 of 27
Median peer was paid$561K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,889 | $88K | |
| 2019 | 80,844 | $82K | |
| 2020 | 81,091 | $83K | |
| 2021 | 108,836 | $132K | |
| 2022 | 139,604 | $130K | |
| 2023 | 147,653 | $123K | |
| 2024incomplete | 109,072 | $68K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19% | 1,961 | 1,702 | $133K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.5% | 40,770 | 34,300 | $60K |
| 85610 | 7.0% | 28,281 | 20,377 | $50K | |
| 84702 | 5.9% | 6,490 | 4,915 | $42K | |
| 88141 | 5.4% | 5,845 | 5,778 | $38K | |
| 36415 | Collection of venous blood by venipuncture | 5.4% | 56,131 | 39,937 | $38K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 2.9% | 22,310 | 13,765 | $20K |
| 85730 | 2.8% | 6,963 | 6,721 | $19K | |
| 83735 | 1.8% | 5,537 | 4,229 | $13K | |
| 82565 | 1.8% | 43,936 | 36,055 | $13K | |
| 81001 | 1.8% | 8,751 | 8,412 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.7% | 610 | 539 | $12K |
80 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.7% | 591 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 589 | $11K |
| 82247 | 1.5% | 31,692 | $11K | |
| 84520 | 1.4% | 43,392 | $10K | |
| 85027 | 1.4% | 8,281 | $10K | |
| 82310 | 1.4% | 42,314 | $10K | |
| 84295 | 1.4% | 42,677 | $10K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.3% | 450 | $9K |
| 87209 | 1.3% | 1,994 | $9K | |
| 84132 | 1.3% | 42,933 | $9K | |
| 82374 | 1.3% | 42,522 | $9K | |
| 88142 | 1.3% | 753 | $9K | |
| 82947 | 1.2% | 42,353 | $9K | |
| 82435 | 1.2% | 42,524 | $9K | |
| 84450 | 1.1% | 29,220 | $7K | |
| 82040 | 1.0% | 30,033 | $7K | |
| 84075 | <1% | 28,741 | $7K | |
| 84460 | <1% | 29,249 | $7K | |
| 87177 | <1% | 1,990 | $7K | |
| 82248 | <1% | 7,035 | $6K | |
| 84155 | <1% | 28,668 | $5K | |
| 84100 | <1% | 4,845 | $4K | |
| 80164 | <1% | 1,099 | $4K | |
| 81513 | <1% | 40 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 326 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 887 | $3K |
| 85652 | <1% | 2,784 | $3K | |
| 87510 | <1% | 237 | $3K | |
| 83690 | <1% | 985 | $3K | |
| 82670 | <1% | 351 | $3K | |
| 87660 | <1% | 205 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 537 | $2K |
| 87480 | <1% | 179 | $2K | |
| 85651 | <1% | 1,256 | $2K | |
| 85379 | <1% | 410 | $2K | |
| 80202 | <1% | 367 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 135 | $2K |
| 83880 | <1% | 768 | $2K | |
| 84144 | <1% | 329 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 56 | $2K |
| 80197 | <1% | 222 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 38 | $2K |
| 87088 | <1% | 334 | $2K | |
| 82150 | <1% | 428 | $1K | |
| 81003 | <1% | 949 | $1K | |
| 82977 | <1% | 585 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 56 | $1K |
| 86803 | <1% | 116 | $967.47 | |
| 80178 | <1% | 321 | $900.69 | |
| 83615 | <1% | 402 | $690.44 | |
| 84550 | <1% | 591 | $656.11 | |
| 87522 | Neg quan hep c or qual rna | <1% | 264 | $637.58 |
| 83002 | <1% | 112 | $605.82 | |
| 82550 | <1% | 182 | $534.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 105 | $434.29 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 53 | $432.18 |
| 80050 | General health panel | <1% | 31 | $410.32 |
| 84146 | <1% | 112 | $405.82 | |
| 87070 | <1% | 102 | $403.30 | |
| 87077 | <1% | 82 | $373.76 | |
| 83001 | <1% | 53 | $366.98 | |
| 80061 | Lipid panel | <1% | 70 | $345.30 |
| 82570 | <1% | 112 | $299.75 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $235.02 |
| 87340 | <1% | 24 | $157.59 | |
| 84703 | <1% | 41 | $156.94 | |
| 85045 | <1% | 88 | $147.47 | |
| 82140 | <1% | 17 | $126.54 | |
| 88112 | <1% | 12 | $123.15 | |
| 84156 | <1% | 60 | $120.51 | |
| 82607 | <1% | 14 | $115.71 | |
| 87186 | <1% | 26 | $115.20 | |
| 85007 | <1% | 71 | $109.33 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 82 | $90.88 |
| 82728 | <1% | 12 | $82.94 | |
| 85018 | <1% | 70 | $51.50 | |
| 81025 | <1% | 13 | $45.33 | |
| 86592 | <1% | 17 | $44.21 | |
| 85014 | <1% | 53 | $36.87 | |
| 36416 | 0% | 674 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWLES, CHARLES (SR. VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.